Page last updated: 2024-09-05

ro 32-3555 and Disease Models, Animal

ro 32-3555 has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grandgirard, D; Leib, SL; Leppert, D; Liechti, FD1
Geary, MB; Hammert, WC; Loiselle, AE; O'Keefe, RJ; Orner, CA1
Bottomley, KM; Brewster, M; Greenham, AK; Lewis, EJ; Wilson, KL1

Other Studies

3 other study(ies) available for ro 32-3555 and Disease Models, Animal

ArticleYear
Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.
    Infection and immunity, 2014, Volume: 82, Issue:4

    Topics: ADAM Proteins; ADAM17 Protein; Animals; Apoptosis; Brain Injuries; Collagen; Cytokines; Disease Models, Animal; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Meningitis, Pneumococcal; Peroxidase; Rats; Sulfonamides; Weight Loss

2014
Low-Dose and Short-Duration Matrix Metalloproteinase 9 Inhibition Does Not Affect Adhesion Formation during Murine Flexor Tendon Healing.
    Plastic and reconstructive surgery, 2016, Volume: 137, Issue:3

    Topics: Analysis of Variance; Animals; Biomechanical Phenomena; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Imidazoles; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Random Allocation; Reference Values; Tendon Injuries; Tensile Strength; Tissue Adhesions; Wound Healing

2016
Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis.
    Arthritis and rheumatism, 1998, Volume: 41, Issue:9

    Topics: Animals; Cartilage, Articular; Disease Models, Animal; Imidazoles; Knee Joint; Male; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Microradiography; Osteoarthritis; Protease Inhibitors

1998